With respect to genomic aberrations in the FGF1 subfamily, a study investigating SNPs and risk of breast cancer found that, on their own, SNPs in FGF1 and FGF2 were not associated with increased risk, but an FGF1 SNP was associated with decreased survival [133]. Here, FGF2 is linked to breast cancer.